376 Results for "

CT

" in MedChemExpress (MCE) Product Catalog:
Products (376)

376 Results for "CT" in MCE Product Catalog:

Cat. No.: HY-153996
CAS No.: 2523435-18-7
Research Areas:  

Cancer

CT1113 is a selective, orally active USP25/USP28 inhibitor. CT1113 inhibits cancer cell proliferation, induces apoptosis, and causes G2/S phase cell cycle arrest. CT1113 reduces the levels of total BCR-ABL1, phosphorylated BCR-ABL1, total STAT5, and phosphorylated STAT5, but does not alter the mRNA level of BCR-ABL1. CT1113 is applicable to research related to pancreatic cancer, colon cancer, and acute leukemia .
loading...
    loading...
Cat. No.: HY-P99620
CAS No.: 1443004-15-6
Synonyms: CT-P22; CT120

Target:  

Influenza Virus

Research Areas:  

Infection

Firivumab (CT-P22; CT120) is a human IgG1 monoclonal influenza A virus hemagglutinin (Anti-IAV HA) antibody. Firivumab is capable of neutralizing H1N1, H5N1, H6N1, H6N2, H8N4, H8N8, H9N2 and H12N7. Firivumab shows protection against H1N1 virus in mice .
loading...
    loading...
Cat. No.: HY-16433
CAS No.: 79714-31-1
Synonyms: CT 112
Risarestat (CT-112), an aldose reductase inhibitor, is developed for the treatment of diabetic complications.
loading...
    loading...
Cat. No.: HY-118982
CAS No.: 166981-13-1
Purity:  95.99%
Research Areas:  

Cancer

CT-2584 is a chemotherapeutic compound that reduces the expression of NKEF-B in several tumor cell types and kills tumor cells by inducing the production of ROS in mitochondria, commonly used in cancer research .
loading...
    loading...
Cat. No.: HY-P99346
CAS No.: 2444308-95-4
Synonyms: CT-P59

Research Areas:  

Infection

Regdanvimab (CT-P59) is a human monoclonal antibody that targets the receptor-binding domain of SARS-CoV-2 spike protein, blocking interaction with ACE2 for viral entry. Regdanvimab can be used for the research of COVID-19 .
loading...
    loading...
Cat. No.: HY-175613
Target:  

FAP

Research Areas:  

Cancer

DOTA-ALB-02 is an albumin-bound FAP inhibitor (FAPI) ligand. DOTA-ALB-02 labeled with 177Lu has a high FAP-binding affinity and enhanced tumor uptake and retention with a significant tumor/nontarget ratio. DOTA-ALB-02 can be used for PET/CT and SPECT/CT imaging of cancers, especially late-stage cancers .
loading...
    loading...
Cat. No.: HY-P990077
CAS No.: 1036730-42-3
Synonyms: CT-011; MDV9300

Target:  

PD-1/PD-L1

Research Areas:  

Cancer

Pidilizumab (CT-011) is a humanized IgG1k anti-PD-1 monoclonal antibody. Pidilizumab acts as a DLL1 antagonist. Pidilizumab has the potential for hematologic malignancies research .
loading...
    loading...
Cat. No.: HY-P990842

Target:  

Glycoprotein VI

Research Areas:  

Cancer

Anti-GPC-2 Antibody (CT3) is a kind of mouse IgG1 κ chimeric antibody, targeting to human GPC-2. Anti-GPC-2 Antibody (CT3) reacts with tumor-associated exons 3 and 10 of glypicans-2 (GPC2). Anti-GPC-2 Antibody (CT3) can be used for the research of cancer, such as neuroblastoma .
loading...
    loading...
Cat. No.: HY-135555
CAS No.: 74885-09-9
Purity:  98.74%
Synonyms: 5-CT
Target:  

5-HT Receptor

Research Areas:  

Neurological Disease

5-Carboxamidotryptamine (5-CT) is a 5-HT1A, 5-HT1B, 5-HT1D, 5-HT5A, 5-HT7 receptor agonist . 5-Carboxamidotryptamine has a Ki value of 4.6 nM for cloned human 5-HT5A receptor. 5-Carboxamidotryptamine causes a dose-dependent reduction in rectal temperature of mice .
loading...
    loading...
Cat. No.: HY-10182C
CAS No.: 2109414-84-6
Synonyms: CHIR-99021 dihydrochloride; CT99021 dihydrochloride
Laduviglusib dihydrochloride (CHIR-99021 dihydrochloride; CT99021 dihydrochloride) is a potent, selective and orally active GSK-3α/β inhibitor with IC50s of 10 nM and 6.7 nM. Laduviglusib dihydrochloride shows >500-fold selectivity for GSK-3 over CDC2, ERK2 and other protein kinases. Laduviglusib dihydrochloride is also a potent Wnt/β-catenin signaling pathway activator. Laduviglusib dihydrochloride enhances mouse and human embryonic stem cells self-renewal. Laduviglusib dihydrochloride induces autophagy .
loading...
    loading...
Cat. No.: HY-176772
CAS No.: 3106015-71-5
Research Areas:  

Cancer

QHL-1618 is a tumor microenvironment-activated drug conjugate. QHL-1618 inhibits the tumor growth in various tumor models, such as HT-1080 xenograft, CT-26 xenograft .
loading...
    loading...
Cat. No.: HY-16449
CAS No.: 937273-04-6
Synonyms: CT-1578
Target:  

JAK FLT3

Research Areas:  

Inflammation/Immunology

SB1578 (CT-1578) is a selective JAK2 and FLT3 inhibitor with an IC50 of 46 nM and 60 nM, respectively. SB1578 exhibits high selectivity for other kinase targets. SB1578 can be used for the study of non-oncology indication rheumatoid arthritis .
loading...
    loading...
Cat. No.: HY-109084A
Synonyms: CT-707 tetrahydrochloride
Target:  

FAK

Research Areas:  

Cancer

Conteltinib tetrahydrochloride (CT-707 tetrahydrochloride) is the tetrahydrochloride salt form of Conteltinib (HY-109084). Conteltinib tetrahydrochloride is the inhibitor for FAK (IC50=1.6 nM), ALK, and Pyk2. Conteltinib tetrahydrochloride exhibits a synergistic anti-tumor efficacy with Cabozantinib (HY-13016) .
loading...
    loading...
Cat. No.: HY-19704
CAS No.: 1233363-33-1
Synonyms: CT327; SNA-120
Target:  

Trk Receptor

Research Areas:  

Inflammation/Immunology Cancer

Pegcantratinib (CT327) is a potent and selective TRKA antagonist with activity against TRKB and TRKC. Pegcantratinib can be used for research of CYLD cutaneous syndrome (CCS) and inflammatory dermatoses, such as psoriasis and concomitant pruritus .
loading...
    loading...
Cat. No.: HY-P11237
CAS No.: 2869147-44-2
Synonyms: CT-388
Enicepatide (CT-388) is a cAMP signal-biased dual GLP-1R and GIPR agonist peptide, with an EC50 value of 0.087 nM for GLP-1R cAMP, and an EC50 value of 2.47 nM for GIPR cAMP. Enicepatide activates the cAMP signaling pathway, while recruiting only minimal amounts of β-arrestin-2 at both targets and reducing receptor internalization levels. Enicepatide improves glycemic control, reduces body weight, suppresses appetite, and ameliorates the pathological conditions of metabolic dysfunction-associated steatohepatitis. Enicepatide can be used in the research of obesity, type 2 diabetes, and metabolic dysfunction-associated steatohepatitis .
loading...
    loading...
Cat. No.: HY-172030
CAS No.: 61638-10-6
Target:  

Drug Derivative

Research Areas:  

Neurological Disease

2C-T hydrochloride is an analog of Mescaline and 2C-T-2 . Mescaline and 2C-T-2 have psychoactive effects.
loading...
    loading...
Cat. No.: HY-175612
Target:  

FAP

Research Areas:  

Cancer

DOTA-ALB-01 is an albumin-bound FAP inhibitor (FAPI) ligand. DOTA-ALB-01 labeled with 68Ga or 177Lu has a high FAP-binding affinity and enhanced tumor uptake and retention. DOTA-ALB-01 can be used for PET/CT and SPECT/CT imaging of cancers, especially late-stage cancers .
loading...
    loading...
Cat. No.: HY-P11318
CAS No.: 2170388-37-9
Target:  

Inhibitory Antibodies

Research Areas:  

Cancer

NOTA-NOC is a peptide conjugated to a radiotracer, such as gallium-68 or fluorine-18, for use in PET/CT scans to diagnose and monitor neuroendocrine tumors .
loading...
    loading...
Cat. No.: HY-119288
CAS No.: 6298-15-3
Purity:  97.37%
Synonyms: NSC 45382
Target:  

Proteasome

Research Areas:  

Cancer

BC-23 (NSC 45382) is a proteasome inhibitor. BC-23 exhibits good inhibition of CT-L activity of the proteasome and is selective for malignant over normal cells .
loading...
    loading...
Cat. No.: HY-P10652
CAS No.: 2094604-98-3
Target:  

Wnt β-catenin

Research Areas:  

Cancer

hsBCL9CT-24 is a Wnt/β-catenin (b-cat) pathway inhibitor with potent anti-tumor effect. hsBCL9CT-24 reactivates anti-cancer immune response suppressed by the oncogenic Wnt pathway and can be utilized for cancer research .
loading...
    loading...